J.P. Morgan is out with its report today on Marvell Technology MRVL, lowering its PT from $24 to $21.
In a note to clients, Citi writes, "Our C11 EPS estimate declines $0.02 to $1.58 while our C12 estimate remains at $1.80. Our new PT of $21 assumes MRVL should trade at 10x our C12 EPS estimate, in line with the group average, plus $3.45 of cash per share on the balance sheet."
J.P. Morgan reiterates Overweight on MRVL.
At the time of posting, shares of MRVL were trading pre-market at $15.80, up 8.52% from Thursday's close.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Posted In: Analyst ColorPrice TargetAnalyst RatingsInformation TechnologyJ.P. MorganMarvell TechnologySemiconductors
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in